Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,160.31 +12.39 0.58%
FTSE 100 5,391.14 +34.80 0.65%
DAX 6,396.84 +73.65 1.16%
Ticker Volume Price Price Delta
Nikkei 8,633.19 -23.89 -0.28%
TOPIX 723.62 -3.41 -0.47%
Hang Seng 18,737.10 -318.40 -1.67%
Gold 1,552.20 +0.08%
EUR-USD 1.2480 -0.1847%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,391.14 +0.65%
STOXX 50 2,160.31 +0.58%
DAX 6,396.84 +1.16%
Oil (WTI) 90.33 -0.47%
U.S. 10-year 1.719% -0.026
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%
  • Fund Type: ETF
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Pharmaceutical ETF

Add to Portfolio

PPH:US

37.2000 USD 0.1000 0.27%

As of 20:04:03 ET on 05/29/2012. Mutual Fund NAVs include dividends.

Snapshot for Market Vectors Pharmaceutical ETF (PPH)

Bid: 37.0000 Open: 37.2300 High - Low: 37.4700 - 37.1300 Primary Exchange: NYSE Arca
Ask: 37.4600 Volume: 18,560 52-Week Range: 35.4150 - 39.0000 Beta vs MVPPHTR: -

ETF Chart for PPH

No chart data available.
  • PPH:US 37.2000
  • 1D
  • 1M
  • 1Y
37.1000
Interactive PPH Chart

Previous Close

Fund Profile & Information for PPH

Market Vectors Pharmaceutical ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Pharmaceutical 25 Index.

Inception Date: 2011-12-21 Telephone: 1-212-293-2000
Managers: HAO-HUNG LIAO "PETER"
Web Site: www.vaneck.com

Fundamentals for PPH

NAV (on 2012-05-29) 37.2293
Assets (M) (on 2012-04-30) 261.7228
Shares out (M) 6.24
Market Cap (M) 232.06
% Premium -0.08
Average 52-Week % Premium -0.0009
Fund Leveraged N

Dividends for PPH

No dividends reported

Performance for PPH

1-Month -4.20% 1-Year -
3-Month -0.37% 3-Year -
Year To Date +2.32% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for PPH

Filing Date: 05/25/2012
Name Position Value % of Total
Johnson & Johnson 324,716 20,297,997 8.768%
Pfizer Inc 891,733 19,734,051 8.524%
Novartis AG 282,559 14,681,766 6.342%
Merck & Co Inc 360,076 13,520,854 5.840%
GlaxoSmithKline PLC 298,524 13,218,643 5.710%
Abbott Laboratories 207,660 12,926,835 5.584%
Eli Lilly & Co 270,578 11,123,462 4.805%
AstraZeneca PLC 261,773 10,792,901 4.662%
Sanofi 313,973 10,772,414 4.653%
Bristol-Myers Squibb Co 323,726 10,712,093 4.627%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements